Pediatrix Medical Group Inc 2024年度报告

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.Yes☒No☐ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirementsfor the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or anemerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” inRule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any newor revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internalcontrol over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issuedits audit report.☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in thefiling reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensationreceived by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Act). Yes☐No☒ The aggregate market value of shares of Common Stock of the registrant held by non-affiliates of the registrant on June 28, 2024, the last business day ofthe registrant’s most recently completed second fiscal quarter, was $637,401,917based on a $7.55 closing price per share as reported on the New York StockExchange composite transactions list on such date. The number of shares of Common Stock of the registrant outstanding on February 14, 2025 was85,829,575. Pediatrix Medical Group, Inc.Annual Report on Form 10-KFor the Year Ended December 31, 2024 INDEX PART I Item 1.Business4Item 1A.Risk Factors26Item 1B.Unresolved Staff Comments49Item 1C.Cybersecurity49Item 2.Properties51Item 3.Legal Proceedings51Item 4.Mine Safety Disclosures51PART IIItem 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases ofEquity Securities52Item 6.Reserved55Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations56Item 7A.Quantitative and Qualitative Disclosures About Market Risk68Item 8.Financial Statements and Supplementary Data69Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure96Item 9A.Controls and Procedures96Item 9B.Other Information96Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections96PART IIIItem 10.Directors, Executive Officers and Corporate Governance97Item 11.Executive Compensation97Item 12.Security Ownership of Certain Beneficial Owners and Management and Related StockholderMatters97Item 13.Certain Relationships and Related Transactions, and Director Independence97Item 14.Principal Accountant Fees and Services98PART IVItem 15.Exhibits, Financial Statement Schedule99Item 16.Form 10-K Summary104 FORWARD-LOOKING STATEMENTS Certain information included or incorporated by reference in this Form 10-K may be deemed to be “forward-lookingstatements” which may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements(other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe oranticipate will or may occur in the future. These statements are often characterized by terminology such as “believe,” “hope,”“may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similarexpressions, and are based on assumptions and assessments made by our management in light of their experience and theirperception of historical trends, current conditions, expected future developments and other factors they believe to be